-96.6%
DFNS vs MRNA
+330.7%
-427.3%
-98.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -11.1% | -3.6% | -7.5% | -11.0% |
| 7D | -13.8% | -20.0% | +6.1% | -13.1% |
| 30D | -65.1% | -1.3% | -63.9% | -65.2% |
| 3M | -95.0% | +240.0% | -335.0% | -95.1% |
| All | -96.6% | +330.7% | -427.3% | -96.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling